Pharmacogenomic biomarkers as clinical decision making tools for clozapine treatment of schizophrenia. CRESTAR (OTHER)

Project: Research

Project Details

StatusFinished
Effective start/end date1/11/2011 → 31/10/2015

Funding

  • EC European Commission: £95,664.00